Clinical trial

Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated Cardiomyopathy

NCT04957147

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention 12 months of guideline-directed heart failure therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated Cardiomyopathy

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-08-01

PhaseN/A

Conditions

Dilated Cardiomyopathyverified · MONDO: dilated cardiomyopathy

Interventions

12 months of guideline-directed heart failure therapyOTHER

Sponsors & collaborators

Imperial College Londonlead sponsor

Royal Brompton & Harefield NHS Foundation Trustcollaborator

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04957147 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.